Patents Assigned to AKANOCURE PHARMACEUTICALS, INC.
  • Publication number: 20230183274
    Abstract: The present technology is directed to polypropionate lactone stereotetrads of Formula (I) (or a pharmaceutically acceptable salt and/or solvate thereof) which are significant intermediates for multiple synthetic applications.
    Type: Application
    Filed: September 19, 2022
    Publication date: June 15, 2023
    Applicant: AKANOCURE PHARMACEUTICALS, INC.
    Inventors: Mohammad N. NOSHI, Philip L. FUCHS
  • Patent number: 11447509
    Abstract: The present technology is directed to polypropionate lactone stereotetrads of Formula (I) (or a pharmaceutically acceptable salt and/or solvate thereof) which are significant intermediates for multiple synthetic applications.
    Type: Grant
    Filed: October 14, 2020
    Date of Patent: September 20, 2022
    Assignee: AKANOCURE PHARMACEUTICALS, INC.
    Inventors: Mohammad N. Noshi, Philip L. Fuchs
  • Publication number: 20210277032
    Abstract: The present technology is directed to polypropionate lactone stereotetrads of Formula (I) (or a pharmaceutically acceptable salt and/or solvate thereof) which are significant intermediates for multiple synthetic applications.
    Type: Application
    Filed: October 14, 2020
    Publication date: September 9, 2021
    Applicant: AKANOCURE PHARMACEUTICALS, INC.
    Inventors: Mohammad N. NOSHI, Philip L. FUCHS
  • Publication number: 20190367540
    Abstract: The present technology is directed to polypropionate lactone stereotetrads of Formula (I) (or a pharmaceutically acceptable salt and/or solvate thereof) which are significant intermediates for multiple synthetic applications.
    Type: Application
    Filed: December 11, 2017
    Publication date: December 5, 2019
    Applicant: AKANOCURE PHARMACEUTICALS, INC.
    Inventors: Mohammad N. NOSHI, Philip L. FUCHS